NEXALIN TECHNOLOGY INC (NXL) Stock Fundamental Analysis

NASDAQ:NXL • US65345B2016

0.427 USD
0 (0%)
Last: Feb 19, 2026, 10:42 AM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NXL. NXL was compared to 185 industry peers in the Health Care Equipment & Supplies industry. NXL has a great financial health rating, but its profitability evaluates not so good. NXL is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • NXL had negative earnings in the past year.
  • In the past year NXL has reported a negative cash flow from operations.
  • In the past 5 years NXL always reported negative net income.
  • NXL had a negative operating cash flow in each of the past 5 years.
NXL Yearly Net Income VS EBIT VS OCF VS FCFNXL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -2M -4M -6M

1.2 Ratios

  • NXL has a Return On Assets of -169.31%. This is amonst the worse of the industry: NXL underperforms 88.11% of its industry peers.
  • NXL has a worse Return On Equity (-182.01%) than 70.81% of its industry peers.
Industry RankSector Rank
ROA -169.31%
ROE -182.01%
ROIC N/A
ROA(3y)-110.33%
ROA(5y)-801.91%
ROE(3y)-127.63%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NXL Yearly ROA, ROE, ROICNXL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

1.3 Margins

  • NXL has a better Gross Margin (69.55%) than 78.38% of its industry peers.
  • NXL's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for NXL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.55%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.73%
GM growth 5Y2.21%
NXL Yearly Profit, Operating, Gross MarginsNXL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K -5K

7

2. Health

2.1 Basic Checks

  • NXL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for NXL has been increased compared to 1 year ago.
  • The number of shares outstanding for NXL has been increased compared to 5 years ago.
  • There is no outstanding debt for NXL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NXL Yearly Shares OutstandingNXL Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
NXL Yearly Total Debt VS Total AssetsNXL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

  • NXL has an Altman-Z score of -15.97. This is a bad value and indicates that NXL is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of NXL (-15.97) is worse than 83.78% of its industry peers.
  • There is no outstanding debt for NXL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -15.97
ROIC/WACCN/A
WACC9.98%
NXL Yearly LT Debt VS Equity VS FCFNXL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

2.3 Liquidity

  • NXL has a Current Ratio of 13.48. This indicates that NXL is financially healthy and has no problem in meeting its short term obligations.
  • NXL has a better Current ratio (13.48) than 97.30% of its industry peers.
  • A Quick Ratio of 13.03 indicates that NXL has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 13.03, NXL belongs to the top of the industry, outperforming 97.30% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 13.48
Quick Ratio 13.03
NXL Yearly Current Assets VS Current LiabilitesNXL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2M 4M 6M

4

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 0.33% over the past year.
  • Looking at the last year, NXL shows a decrease in Revenue. The Revenue has decreased by -3.09% in the last year.
  • The Revenue has been decreasing by -4.05% on average over the past years.
EPS 1Y (TTM)0.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.48%
Revenue 1Y (TTM)-3.09%
Revenue growth 3Y5.39%
Revenue growth 5Y-4.05%
Sales Q2Q%-49.58%

3.2 Future

  • The Earnings Per Share is expected to grow by 16.65% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 95.89% on average over the next years. This is a very strong growth
EPS Next Y19.67%
EPS Next 2Y16.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year34.3%
Revenue Next 2Y95.89%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NXL Yearly Revenue VS EstimatesNXL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 200K 400K 600K 800K 1M
NXL Yearly EPS VS EstimatesNXL Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.2 -0.4 -0.6

0

4. Valuation

4.1 Price/Earnings Ratio

  • NXL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year NXL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXL Price Earnings VS Forward Price EarningsNXL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NXL Per share dataNXL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as NXL's earnings are expected to grow with 16.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.65%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for NXL!.
Industry RankSector Rank
Dividend Yield 0%

NEXALIN TECHNOLOGY INC

NASDAQ:NXL (2/19/2026, 10:42:12 AM)

0.427

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-14
Earnings (Next)03-12
Inst Owners3.78%
Inst Owner Change64.78%
Ins Owners12.78%
Ins Owner Change5.82%
Market Cap7.96M
Revenue(TTM)157.00K
Net Income(TTM)-8.68M
Analysts80
Price Target4.08 (855.5%)
Short Float %0.92%
Short Ratio0.49
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)11.01%
Min EPS beat(2)-7.26%
Max EPS beat(2)29.28%
EPS beat(4)1
Avg EPS beat(4)-39.38%
Min EPS beat(4)-131.02%
Max EPS beat(4)29.28%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)21.47%
Min Revenue beat(2)-55.07%
Max Revenue beat(2)98.02%
Revenue beat(4)2
Avg Revenue beat(4)12.01%
Min Revenue beat(4)-55.07%
Max Revenue beat(4)98.02%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 50.72
P/FCF N/A
P/OCF N/A
P/B 1.67
P/tB 1.79
EV/EBITDA N/A
EPS(TTM)-0.66
EYN/A
EPS(NY)-0.39
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS0.01
BVpS0.26
TBVpS0.24
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -169.31%
ROE -182.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69.55%
FCFM N/A
ROA(3y)-110.33%
ROA(5y)-801.91%
ROE(3y)-127.63%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.73%
GM growth 5Y2.21%
F-Score2
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 92.42%
Cap/Sales 11.66%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 13.48
Quick Ratio 13.03
Altman-Z -15.97
F-Score2
WACC9.98%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.48%
EPS Next Y19.67%
EPS Next 2Y16.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.09%
Revenue growth 3Y5.39%
Revenue growth 5Y-4.05%
Sales Q2Q%-49.58%
Revenue Next Year34.3%
Revenue Next 2Y95.89%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-32.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-32.27%
OCF growth 3YN/A
OCF growth 5YN/A

NEXALIN TECHNOLOGY INC / NXL FAQ

Can you provide the ChartMill fundamental rating for NEXALIN TECHNOLOGY INC?

ChartMill assigns a fundamental rating of 3 / 10 to NXL.


Can you provide the valuation status for NEXALIN TECHNOLOGY INC?

ChartMill assigns a valuation rating of 0 / 10 to NEXALIN TECHNOLOGY INC (NXL). This can be considered as Overvalued.


How profitable is NEXALIN TECHNOLOGY INC (NXL) stock?

NEXALIN TECHNOLOGY INC (NXL) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for NXL stock?

The Earnings per Share (EPS) of NEXALIN TECHNOLOGY INC (NXL) is expected to grow by 19.67% in the next year.